Relationship between dose of antithyroid drugs and adverse events in pediatric patients with Graves’ disease

Graves’ disease (GD) accounts for a large proportion of pediatric hyperthyroidism, and the first-line treatment is antithyroid drug (ATD) therapy. Methimazole (MMI) is effective in most patients but is associated with significant adverse events (AEs). We reviewed the medical records of GD patients (...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasuda, Kie, Miyoshi, Yoko, Tachibana, Makiko, Namba, Noriyuki, Miki, Kazunori, Nakata, Yukiko, Takano, Toru, Ozono, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Pediatric Endocrinology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295245/
https://www.ncbi.nlm.nih.gov/pubmed/28203042
http://dx.doi.org/10.1297/cpe.26.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295245/
https://www.ncbi.nlm.nih.gov/pubmed/28203042
http://dx.doi.org/10.1297/cpe.26.1

Ejemplares similares